Navigation Links
Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group

Major Bleeding in Patients Treated for Acute Coronary Syndromes (ACS) Nearly Triples the Risk of Death at One Year

NEW ORLEANS, March 26, 2007 /PRNewswire/ -- One-year findings from the landmark ACUITY trial show that acute coronary syndrome (ACS) patients in the "Angiomax(R) (bivalirudin) alone" treatment group had similar rates of ischemic clinical outcomes compared with more complicated standard therapy, confirming previous findings, which showed similar ischemia at 30 days, and nearly 50% fewer episodes of major bleeding. At one year, the mortality rate of patients treated in the Angiomax alone treatment group was 3.8%, compared to 4.4% in the control treatment group. A separate analysis found that, in patients with ACS, having a major bleeding episode within 30 days following treatment nearly triples the risk of death up to one year later, making major bleeding a more powerful predictor of mortality than even a heart attack.

The ACUITY one-year results were presented as late-breaking findings by investigators for the first time here at the i2 Summit at the 56th Annual Scientific Session of the of Cardiology. Collectively, the data showed that ACUITY met all primary one-year endpoints and confirmed previously published 30-day findings. The Medicines Company markets Angiomax, an anti-clotting agent, in the United States.

"Our findings are important because they demonstrate that in high risk patients with ACS, Angiomax, the simplest and least expensive regimen, results in the overall best clinical outcomes," said ACUITY's principal investigator, Gregg W. Stone, MD, professor of medicine and director of cardiovascular research and education at Medical Center's Center for Interventional Vascular Therapy, and chairman of the Cardiovascular Research Foundation.

Study Findings

The one-year ACUITY analysis showed that treatment in the Angiomax(R)(bivalirudin) alone group resulted in comp
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
5. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
6. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
7. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
8. EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3 Clinical Trial at 47th Annual NCDEU Meeting
9. Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency
10. Prana Biotechnology Presents New Key Findings on PBT2
11. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD
Post Your Comments:
(Date:5/22/2013)... -- Milliman, Inc., a premier global consulting and actuarial firm, ... Index (MMI), which measures the healthcare costs for a ... an employer-sponsored preferred provider organization (PPO) plan. The cost ... $22,030. "For the second consecutive year, ... basis was the lowest in the history of the ...
(Date:5/22/2013)... , 22. Mai 2013 Kepner-Tregoe ... Beratung, gab heute bekannt, dass der Veteran ... , zum Hauptgeschäftsführer ernannt wurde. Geraghty,s ... Industriebereich wo er zahlreiche Führungspositionen bei Fertigungsunternehmen ... Baxter an, der als Kepner-Tregoe Hauptgeschäftsführer gedient ...
(Date:5/22/2013)... STEPh, Inc., a full service medical communications ... web site ( http://www.stephreports.com ) dedicated to ... STEPh Reports STEPh Reports are comprehensive critical ... STEPh Report assesses the competitive landscape by individual drug ... and specific key issues.  STEPh Reports are written by ...
Breaking Medicine Technology:Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2
... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), ... associated with inflammation, today announced it will hold a ... investigation and remediation plans relating to vial problems in ... 14, 2010Time: , 5:00 pm Eastern TimeDomestic Dial-in: , ...
... 9, 2010 HeartWare International, Inc. (Nasdaq: ... offer, subject to market and other conditions, $100 million ... "notes") pursuant to an effective shelf registration statement filed ... also intends to grant the underwriters an option to ...
Cached Medicine Technology:Anthera Announces Update Call Regarding Vial Problems 2HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock 2HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock 3
(Date:5/22/2013)... Researchers in genomic health disparities from the University of ... School of Medicine have teamed up to hold the ... Health Disparities in Genomic Medicine." The theme of ... business and government to reduce these disparities. , Despite ... States, individuals within underserved groups continue to be more ...
(Date:5/22/2013)... Hopkins researchers report that hospitals may be reaping ... complicated by preventable bloodstream infections contracted in their ... study, reported online in the American Journal ... an ICU patient who develops an avoidable central ... more to care for than a similar infection-free ...
(Date:5/22/2013)... May 22, 2013 Recent tragedies ... and the school shooting in Newtown, Connecticut all ... , Emergency medical practitioners train to ... the Emergency Medical Services for Children (EMSC) Program ... care for the youngest patients. It is estimated ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Space Girl ... as a sponsor for this weekend's I Talk to Strangers ... at 8:00 am at Cocoa Riverside Park in Cocoa, FL. ... the I Talk to Strangers social movement. , As a ... and walkers to participate in the event. Additionally, they are ...
(Date:5/22/2013)... Pamela Isom, President and CEO of ICE ... 2013 Women of Influence Award in recognition for her ... reception took place on Thursday, May 2 at The ... particularly humbling for the 5,000 people ICE Safety Solutions ... to recognize the four to nine lives saved per ...
Breaking Medicine News(10 mins):Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:Space Girl Organics to Sponsor May 25 Miracle Run/Walk 2Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2
... as HIV and Hepatitis C decades back, will now get ... inquiry is soon to be launched into the contracting of ... transfusions, in what is acknowledged as the biggest treatment blunder ... , The incident took place in the late 70s ...
... study has revealed for the first time that rice bran ... research was conducted by biomedical scientists at the Department of ... has not been tested on humans, but research in the ... has been published in the British Journal of Cancer. ...
... of the “triple negative” type are destructive and lethal, and ... a novel// study Published in the May 1, 2007 issue ... tumors occur commonly among women who are African American and ... lower socioeconomic status (SES). The study also showed that triple ...
... cells to regenerate healthy human liver tissue in a ... the liver, some patients are unable to undergo surgery, ... liver to support the body. ,Researchers at ... cells to help quickly regenerate healthy liver tissue, enabling ...
... technology has found that the most potent cholesterol-lowering ... in the blood vessels that can lead to ... thickened carotid arteries compared to a placebo,” said ... of endocrinology at Wake Forest University School of ...
... southern Indian state of Karnataka is examining a proposal to ... test before marriage. ,State Health Minister R. ... government had written a letter to the federal government suggesting ... were several instances in which unsuspecting women had married HIV+ ...
Cached Medicine News:Health News:Inquiry into Past NHS Treatment Disaster 2Health News:'Triple Negative' Breast Cancers Seem to Affect the Young, Minority 2Health News:Stem Cells to Treat Liver Cancer 2Health News:Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis 2
ScanGel® Centrifuge...
BIOVUE cassettes may be used manually, with a workstation consisting of a centrifuge, incubator, precision pipettes and work rack....
... The ID-Micro Typing System™ ... for a broad range of ... include antibody screening and identification, ... phenotyping, compatibility testing, reverse serum ...
... accommodates up to 12 large slab gels, ... the PROTEAN IEF system, for high-throughput 2-D ... Plus Dodeca cell's cooling and recirculating capabilities, ... high-resolution results. The handcasting system includes the ...
Medicine Products: